News

The product candidate is developed for the indications of refractory and tophaceous gout, which result from elevated levels of uric acid within the body that cause debilitating pain

OM results in the painful inflammation and ulceration of the membranes lining the oral cavity, throat, and esophagus and is among the most frequently reported adverse events associated

Cyclosporine A, when administered systemically (Sandimmune, Neoral), is an effective treatment for psoriasis, atopic dermatitis, pemphigus vulgaris and other severe inflammatory dermatoses. Dr. Daniel Teper, the CEO of

The trial, being carrying out at MAC Clinical Research in Manchester, UK, will evaluate the safety and efficacy of oral ZPL-389 in the treatment of inflammatory skin diseases,

Results from the trial show that d-Methadone was generally well tolerated and a maximum tolerated dose (MTD) was achieved. The company said that the planned multiple ascending dose

The trial is being carried out at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, US.

AATD is a rare genetic disease that severely damages the liver and lungs of affected children and adults. Currently, the company is conducting part B of a Phase

Currently, AG-120 is being evaluated in a Phase I clinical trial in patients with advanced hematologic malignancies that carry an IDH1 mutation. AML is characterized by rapid disease

The breakthrough therapy status is designed to expedite the development and review of medicines intended to treat serious diseases as well as help ensure patients have access to